<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7633">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03007563</url>
  </required_header>
  <id_info>
    <org_study_id>2014/619</org_study_id>
    <nct_id>NCT03007563</nct_id>
  </id_info>
  <brief_title>Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice</brief_title>
  <official_title>Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Olavs Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neonatal jaundice is a common and most often harmless condition. However, when unrecognized
      it can be fatal or cause serious brain injury. Three quarters of these deaths are estimated
      to occur in the poorest regions of the world. The treatment of jaundice, phototherapy, is in
      most cases easy, low-cost and harmless. The crucial point in reducing the burden of disease
      is therefore to identify then children at risk. This results in the need for low-cost,
      reliable and easy-to-use diagnostic tools that can identify newborns with jaundice.

      Based on previous research on the bio-optics of jaundiced newborn skin, a prototype of a
      smartphone application has been developed. This prototype will be evaluated in a clinical
      trial at St.Olav Hospital, Trondheim, Norway. A smartphone will be used to take picture of
      the skin of the newborn, and by using an algorithm an estimate of the bilirubin
      concentration is made. The results from these estimates will be compared to the bilirubin
      levels measured in standard blood samples, as well as the results from ordinary
      transcutaneous measurement devices.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between bilirubin estimates by smartphone pictures and by blood samples</measure>
    <time_frame>5 minutes</time_frame>
    <description>Estimate of bilirubin levels from smartphone pictures, compared with bilirubin measurement in blood samples in a correlation study. Correlation will be expressed by Pearson correlation coefficient, r.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between bilirubin estimates by smartphone pictures and by transcutaneous measurements</measure>
    <time_frame>5 minutes</time_frame>
    <description>Estimate of bilirubin levels from smartphone pictures, compared with bilirubin measurements from transcutaneous devices in a correlation study. Correlation will be expressed by Pearson correlation coefficient, r.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Jaundice, Neonatal</condition>
  <condition>Hyperbilirubinemia, Neonatal</condition>
  <arm_group>
    <arm_group_label>newborn infants checked for jaundice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>an experimental way of bilirubin concentration estimation from smartphone pictures is applied and compared with two standard methods: bilirubin concentration measured in standard blood samples, and bilirubin concentration measured by transcutaneous device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bilirubin concentration estimation from smartphone pictures</intervention_name>
    <description>pictures taken of the skin covering the breast bone</description>
    <arm_group_label>newborn infants checked for jaundice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bilirubin concentration measured in standard blood samples</intervention_name>
    <arm_group_label>newborn infants checked for jaundice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bilirubin concentration measured by transcutaneous device</intervention_name>
    <arm_group_label>newborn infants checked for jaundice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  born in St.Olavs hospital, Trondheim, Norway

          -  born at term

          -  normal birth weight

        Exclusion Criteria:

          -  in need of advanced medical treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Siri Forsmo, md prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anders Aune</last_name>
    <email>a.aune@ntnu.no</email>
  </overall_contact>
  <reference>
    <citation>Carceller-Blanchard A, Cousineau J, Delvin EE. Point of care testing: transcutaneous bilirubinometry in neonates. Clin Biochem. 2009 Feb;42(3):143-9. doi: 10.1016/j.clinbiochem.2008.09.106. Epub 2008 Oct 2. Review.</citation>
    <PMID>18929553</PMID>
  </reference>
  <reference>
    <citation>Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, Bell J, Mori R, Slusher TM, Fahmy N, Paul VK, Du L, Okolo AA, de Almeida MF, Olusanya BO, Kumar P, Cousens S, Lawn JE. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013 Dec;74 Suppl 1:86-100. doi: 10.1038/pr.2013.208. Review.</citation>
    <PMID>24366465</PMID>
  </reference>
  <reference>
    <citation>Hansen TW. Prevention of neurodevelopmental sequelae of jaundice in the newborn. Dev Med Child Neurol. 2011 Sep;53 Suppl 4:24-8. doi: 10.1111/j.1469-8749.2011.04059.x. Review.</citation>
    <PMID>21950390</PMID>
  </reference>
  <reference>
    <citation>KÃ¤llander K, Tibenderana JK, Akpogheneta OJ, Strachan DL, Hill Z, ten Asbroek AH, Conteh L, Kirkwood BR, Meek SR. Mobile health (mHealth) approaches and lessons for increased performance and retention of community health workers in low- and middle-income countries: a review. J Med Internet Res. 2013 Jan 25;15(1):e17. doi: 10.2196/jmir.2130. Review.</citation>
    <PMID>23353680</PMID>
  </reference>
  <reference>
    <citation>Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med. 2000 Apr;154(4):391-4.</citation>
    <PMID>10768679</PMID>
  </reference>
  <reference>
    <citation>Slusher TM, Olusanya BO, Vreman HJ, Wong RJ, Brearley AM, Vaucher YE, Stevenson DK. Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial. Trials. 2013 Dec 28;14:446. doi: 10.1186/1745-6215-14-446.</citation>
    <PMID>24373547</PMID>
  </reference>
  <reference>
    <citation>Slusher TM, Zipursky A, Bhutani VK. A global need for affordable neonatal jaundice technologies. Semin Perinatol. 2011 Jun;35(3):185-91. doi: 10.1053/j.semperi.2011.02.014. Review.</citation>
    <PMID>21641493</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 28, 2016</lastchanged_date>
  <firstreceived_date>December 20, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diagnosis</keyword>
  <keyword>Cell Phones</keyword>
  <keyword>Infant, Newborn</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Hyperbilirubinemia</mesh_term>
    <mesh_term>Jaundice, Neonatal</mesh_term>
    <mesh_term>Hyperbilirubinemia, Neonatal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bilirubin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
